Otonomy to Participate in Two Upcoming Investor Conferences

Back to Jobs

SAN DIEGO , March 05, 2019 (GLOBE NEWSWIRE) — Otonomy , Inc. (NASDAQ: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced that David A. Weber , Ph.D., president and chief executive officer, is scheduled to participate in two

Apply Now